All-trans retinoic acid and protein kinase C α/β1 inhibitor combined treatment targets cancer stem cells and impairs breast tumor progression

Breast cancer is the leading cause of cancer death among women worldwide. Blocking a single signaling pathway is often an ineffective therapy, especially in the case of aggressive or drug-resistant tumors. Since we have previously described the mechanism involved in the crosstalk between Retinoic Ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Berardi, Damian Emilio, Ariza Bareño, Lizeth, Amigo, Natalia, Cañonero, Luciana, Pelagatti, Maria de las Nieves, Motter, Andrea Nora, Taruselli, María Agustina, Díaz Bessone, María Inés, Cirigliano, Stefano Martin, Edelstein, Alexis, Peters, María Giselle, Diament, Miriam, Urtreger, Alejandro Jorge, Todaro, Laura Beatriz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961031/
https://www.ncbi.nlm.nih.gov/pubmed/33723318
http://dx.doi.org/10.1038/s41598-021-85344-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961031/
https://www.ncbi.nlm.nih.gov/pubmed/33723318
http://dx.doi.org/10.1038/s41598-021-85344-w

Ejemplares similares